SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
GlycoVaxyn AG Announces Strategic Collaboration With GlaxoSmithKline to Develop New Bacterial Vaccines using GlycoVaxyn's Bio-Conjugation Technology